Cartesian Therapeutics Inc (RNAC)

Currency in USD
6.395
-0.095(-1.46%)
Real-time Data·
Advertisement

Cartesian Therapeutics (RNAC) Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell

Technical Indicators

Strong Sell

Moving Averages

Strong Sell

Summary:Strong Sell

Moving Averages:Strong SellBuy: (2)Sell: (10)
Technical Indicators:Strong SellBuy: (0)Sell: (7)

Technical Indicators

Summary: Strong SellBuy: 0Neutral: 1Sell: 7
Nov 2, 2026 15:42 GMT
Name
Value
Action
RSI(14)42.719Sell
STOCH(9,6)20.051Sell
STOCHRSI(14)0.000Oversold
MACD(12,26)-0.003Sell
ADX(14)13.438Neutral
Williams %R-89.000Oversold
CCI(14)-66.8116Sell
ATR(14)0.1218Less Volatility
Highs/Lows(14)-0.1950Sell
Ultimate Oscillator27.876Oversold
ROC-6.449Sell
Bull/Bear Power(13)-0.0392Sell

Moving Averages

Summary: Strong SellBuy: 2Sell: 10
Nov 2, 2026 15:42 GMT
Name
Simple
Exponential
MA5
6.485
Sell
6.490
Sell
MA10
6.519
Sell
6.528
Sell
MA20
6.630
Sell
6.549
Sell
MA50
6.449
Buy
6.512
Sell
MA100
6.448
Buy
6.577
Sell
MA200
6.834
Sell
6.965
Sell

Pivot Points

Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic6.0876.2436.3676.5236.6476.8036.926
Fibonacci6.2436.3506.4166.5236.6306.6966.803
Camarilla6.4136.4396.4646.5236.5166.5416.567
Woodie's6.0706.2356.3506.5156.6306.7956.910
DeMark's--6.4456.5626.725--

FAQ

Is Cartesian Therapeutics (RNAC) a Buy or Sell, from a Technical Analysis Perspective?

Based on moving averages and other technical indicators, today's Cartesian Therapeutics buy/sell signal is Strong Sell.

What Do The Current Moving Averages for Cartesian Therapeutics (RNAC) Show?

The moving averages for Cartesian Therapeutics show a Strong Sell outlook, considering moving averages ranging from MA5 to MA200, with 1 Buy signals and 11 Sell signals.

What Do Today's Technical Indicators for Cartesian Therapeutics Show?

The technical indicators for Cartesian Therapeutics are in a Strong Sell position based on daily analysis, with 2 signals on buy indicators and 5 sell signals.

What Is Cartesian Therapeutics (RNAC)'s 14-Day RSI?

The current Relative Strength Index (RSI) of RNAC over the 14-day period is 42.719, which suggests that the stock is a Sell.

What Is Cartesian Therapeutics (RNAC)'s MACD?

RNAC's MACD (Moving Average Convergence/Divergence) is -0.003, which suggests that the stock is a Sell.

What Is Cartesian Therapeutics (RNAC)'s 5-Day Moving Average?

RNAC's 5-day moving average is 6.485, suggesting that the stock is a Sell.

What Is Cartesian Therapeutics (RNAC)'s 50-Day Moving Average?

RNAC's 50-day moving average is 6.449, suggesting that the stock is a Buy.

What Is Cartesian Therapeutics (RNAC)'s 200-Day Moving Average?

RNAC's 200-day moving average is 6.834, suggesting that the stock is a Sell.

What Is the Fibonacci Pivot Point Performance Value for Cartesian Therapeutics (RNAC)?

The Fibonacci pivot point performance value for RNAC is 6.523.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.